Cerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease. - Test2 - elhamkhani - TriplyDB

Cerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease.

Cerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease.

http://www.wikidata.org/entity/Q36382217

about

Photoacoustic and photothermal detection of circulating tumor cells, bacteria and nanoparticles in cerebrospinal fluid in vivo and ex vivo Sensitivity and specificity of diagnostic accuracy in Alzheimer's disease: a synthesis of existing evidence.Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease CSF phospho-tau correlates with behavioural decline and brain insoluble phospho-tau levels in a rat model of tauopathy.Using biomarkers to improve detection of Alzheimer's disease.Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease Use of CSF α-synuclein in the differential diagnosis between Alzheimer's disease and other neurodegenerative disorders.Glyceraldehyde caused Alzheimer's disease-like alterations in diagnostic marker levels in SH-SY5Y human neuroblastoma cells Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.Tau-based treatment strategies in neurodegenerative diseases Biochemical studies in Normal Pressure Hydrocephalus (NPH) patients: change in CSF levels of amyloid precursor protein (APP), amyloid-beta (Aβ) peptide and phospho-tau Searching for MIND: microRNAs in neurodegenerative diseases.Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly.Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease.A multinational study distinguishing Alzheimer's and healthy patients using cerebrospinal fluid tau/Aβ42 cutoff with concordance to amyloid positron emission tomography imaging.Structural magnetic resonance imaging-derived biomarkers for Alzheimer's disease.Cerebrospinal fluid biomarkers for Alzheimer's disease: the present and the future.The development of effective biomarkers for Alzheimer's disease: a review.CSF Biomarkers for Alzheimer's Disease Diagnosis.CSF Biomarkers Profile in CADASIL-A Model of Pure Vascular Dementia: Usefulness in Differential Diagnosis in the Dementia Disorder.Mass-Spectrometry-Based Method To Quantify in Parallel Tau and Amyloid β 1-42 in CSF for the Diagnosis of Alzheimer's Disease.Elevated cerebrospinal fluid tau protein levels in Wernicke's encephalopathy.Redox-reactive antiphospholipid antibody differences between serum from Alzheimer's patients and age-matched controls.Biomarker identification for diagnosis of Alzheimer's disease.

P2860

Q30437587-B0EE6103-B3C5-42A4-B9AE-3F370B9158BB Q34728483-70970F2F-5710-46E4-A6DE-845B1B62E107 Q34802970-FC05057C-D987-404E-967A-FB08F9793097 Q35114771-ED9AA22B-6A1C-4BA4-9CE4-DC118CF64AA4 Q35533115-CAC5ACB3-3BC5-402C-940E-8D786268279A Q35579334-80987CB9-277B-4569-AA44-F7D6060877F7 Q35597118-8933F4F5-11E0-433E-AC20-234BF19709E1 Q35993403-96AD1A8A-632E-4F73-8CB4-E1BD9BB259BF Q37068847-C887BEDA-9BB3-47F6-B9DD-E17BC343617C Q37215861-67C69B0D-0C55-400E-BA6F-D384BD5E7940 Q37269006-290FE7FD-A695-4582-962B-C7E3C7BAF141 Q37314913-9E69B74E-E76D-413F-B3EF-77500BDA5EC5 Q37524486-F43CA974-1491-4262-89C7-766B5E25F953 Q37630546-596E830C-E264-4144-87A4-E9B65190EA00 Q37710439-10750D52-F299-46B7-B45F-34F1DFA56AC7 Q37755134-A85460A0-303B-472B-BB15-D4DE63D3A2BC Q37895052-B03973E6-6414-48C3-8795-ED5EF36071B8 Q38016800-FBB2B16C-E404-4E80-BAE5-1E958BFCB6F8 Q41897818-61FE11B3-9F87-42F2-BB96-6E93D60B3793 Q42091274-2505DC4E-5FB4-4DCC-86C5-EA8F00FEDEF4 Q46161119-D3DF40EE-1579-4B91-8CC1-F1BB4AC8BDE1 Q46620440-15BE9B42-4FCF-49A3-A7EA-1D9877F8F2E7 Q53405680-9C55BF0A-D848-49FD-AD24-9CB2217D719A Q53480286-63F505B5-91C4-4FF4-BA45-A252AB262389

P2860

Cerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease.

http://www.wikidata.org/entity/Q36382217

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Cerebrospinal fluid tau, A bet ...... gnosis of Alzheimer's disease.

@ast

Cerebrospinal fluid tau, A bet ...... gnosis of Alzheimer's disease.

@en

type

label

Cerebrospinal fluid tau, A bet ...... gnosis of Alzheimer's disease.

@ast

Cerebrospinal fluid tau, A bet ...... gnosis of Alzheimer's disease.

@en

prefLabel

Cerebrospinal fluid tau, A bet ...... gnosis of Alzheimer's disease.

@ast

Cerebrospinal fluid tau, A bet ...... gnosis of Alzheimer's disease.

@en

P1433

Q36382217-0939BA1A-2BCC-4E98-A35E-1B147BF93278

P1476

Q36382217-35660C97-7671-4678-81B8-8FF605611471

P2093

Q36382217-6628A7F9-43BE-4086-8566-850F2DFFFF14

Q36382217-956D4BDD-D70F-4F97-86F5-843E7ECA3FA8

Q36382217-BC4CA026-3260-4F52-831C-E8694B400BC2

P2860

Q36382217-07FB9541-1BC7-4DAF-9E18-BC6BAB6C1E7D

Q36382217-09973C9E-A205-45E7-8C2E-E496F5358AC2

Q36382217-0AE9F496-E4DD-4FB0-86E3-3699EEE91DC6

Q36382217-0CA562EF-645E-48EE-A797-92631BC321FD

Q36382217-10BC03AC-D874-41B2-A0C4-5FE67593C1E5

Q36382217-12B08ACE-6A64-48B4-972F-C5D4360C97DC

Q36382217-155846E9-DC70-458C-83BF-D77EAE2E1004

Q36382217-158D341E-781F-43F4-AB85-E0D72F9C3FC0

Q36382217-16F76CD7-47E0-41BB-9E1A-C2CCDA435955

Q36382217-1E3934C8-C9CF-48C6-BCD5-600ED11F623B

P304

Q36382217-A3C5F663-7E91-41F0-90EB-7097FFFE80F2

P31

Q36382217-722FC329-5A00-4827-829F-309AA8337B2C

P356

Q36382217-4D6B6C77-0812-45EE-9F56-50E298231A92

P433

Q36382217-45DAC5B9-A457-45E0-9ADD-03C132C8695A

P478

Q36382217-82DB6DF9-232B-49E6-81E6-AF04E79D4BA9

P50

Q36382217-5B4F563E-F682-4D80-8E9A-E22526170E84

P577

Q36382217-465AC548-D3CB-4E8D-BFD6-F98F720E09AD

P5875

Q36382217-7CC34F0A-C5C2-47F9-B2C5-22E7C56DB5AF

P698

Q36382217-D79153B6-9278-4EC0-ADE0-AAC02AAA8B48

P921

Q36382217-66AE4DE0-81F7-4BE3-B8D4-02A651D2D9E0

Q36382217-6F34041F-F41E-41A0-9093-6D7C85B20494

Q36382217-9A9CC053-8076-43D9-A987-4A864B0611EE

P356

P1433

Journal of Cellular Physiology

P1476

Cerebrospinal fluid tau, A bet ...... agnosis of Alzheimer's disease

@en

P2093

Carla Battisti

http://www.w3.org/2001/XMLSchema#string

Elena Radi

http://www.w3.org/2001/XMLSchema#string

Patrizia Formichi

http://www.w3.org/2001/XMLSchema#string

P2860

Tau pathology in Alzheimer disease and other tauopathies

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease

Combined analysis of CSF betaA42 peptide and tau protein and serum antibodies to glycosaminoglycans in Alzheimer's disease: preliminary data.

Total tau protein immunoreactivity in lumbar cerebrospinal fluid of patients with Alzheimer's disease.

CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease.

Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles.

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.

O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease

P304

39-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCP.20602

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

208

http://www.w3.org/2001/XMLSchema#string

P50

Antonio Federico

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7327195

http://www.w3.org/2001/XMLSchema#string

P698

16447254

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

phosphorylation

cerebrospinal fluid